brain function and the menopause

Grey matter—the brain tissue rich in neuron cell bodies, synapses, and capillaries—plays a central role in memory, attention, emotional regulation, and decision-making. Like many aspects of biology, grey matter changes across the lifespan, and those changes can be influenced not only by chronological ageing but also by hormonal shifts, including the decline in oestrogen that occurs during menopause.

How grey matter changes with age

Normal ageing is associated with gradual reductions in total brain volume, including grey matter. This process is not uniform: some regions shrink more than others. Areas involved in executive function (such as the prefrontal cortex), memory (notably the hippocampus), and sensory integration tend to show the most noticeable decline. These structural changes reflect multiple biological processes, including reduced synaptic density, changes in dendritic branching, vascular alterations, and low-grade inflammation.

Importantly, grey matter loss with age does not necessarily translate directly into cognitive impairment. Many people maintain excellent cognitive function well into later life, thanks to factors such as cognitive reserve, education, physical activity, social engagement, sleep quality, and cardiovascular health.

The role of oestrogen in the brain

Oestrogen is not only a reproductive hormone—it also has neuroprotective effects. Oestrogen receptors are widely distributed throughout the brain, especially in regions important for memory and mood. Research shows that oestrogen can:

• Promote synaptic plasticity (the brain’s ability to form new connections)

• Support mitochondrial function and energy metabolism

• Reduce inflammation and oxidative stress

• Influence neurotransmitter systems such as serotonin and dopamine

During menopause, oestrogen levels decline significantly. This hormonal shift has been associated with accelerated changes in certain brain regions, particularly those linked to memory and emotional processing. Some imaging studies suggest that perimenopause and early postmenopause may involve temporary reductions in grey matter volume or metabolic activity, although the brain often shows adaptive changes over time.

Does HRT or oestrogen therapy affect grey matter?

Hormone replacement therapy (HRT), including oestrogen therapy, may help preserve grey matter or slow age-related decline.

The evidence so far is mixed but promising in specific contexts:

• Potential benefits: Some studies show that women who start HRT near the onset of menopause (sometimes called the “critical window” or “timing hypothesis”) may have greater grey matter volume in certain brain regions compared with those who never used HRT. Improvements in brain metabolism and connectivity have also been observed.

• Neutral findings: Other studies find little or no structural difference, suggesting that effects may depend on individual factors such as genetics, age at initiation, formulation (oral vs transdermal), and whether progesterone is included.

• Timing matters: Starting HRT many years after menopause does not appear to provide the same neurological benefits and may carry different risks.

The bigger picture

While HRT may help some women maintain brain structure or function during the menopausal transition, it is not primarily prescribed for brain health. Its main indications remain relief of menopausal symptoms (such as hot flashes) and prevention of bone loss in appropriate candidates. Decisions about HRT should always involve personalised risk–benefit discussions with a healthcare professional.

Lifestyle factors—regular exercise, sleep, nutrition, stress management, and cognitive stimulation—remain among the most powerful tools for supporting grey matter health across ageing and menopause.